Regulation of vascular permeability by sphingosine 1-phosphate

Microvascular Research

Volumn 77, Issue 1, 2009, Pages 39-45

  Wang, Lichun ^a   Dudek, Steven M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Actin cytoskeleton; Adherens junction; Focal adhesion; G protein coupled receptor (GPCR); Rac GTPase; Sphingosine 1 phosphate (S1P); Sphingosine 1 phosphate receptor 1 (S1P1); Tight junction; Vascular permeability

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE; RHO KINASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ACUTE LUNG INJURY; ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CYTOSKELETON; ENDOTHELIUM; FOCAL ADHESION; HUMAN; IN VIVO STUDY; LIGATION; METASTASIS; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SEPSIS; TIGHT JUNCTION; TRANSACTIVATION;

ACUTE LUNG INJURY; ANIMALS; CAPILLARY PERMEABILITY; CYTOSKELETON; FOCAL ADHESIONS; HUMANS; INTERCELLULAR JUNCTIONS; LYSOPHOSPHOLIPIDS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 59849085488     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.09.005     Document Type: Review

References (71)

1. Andriopoulou P., et al. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2286-2297
2. Aschner J.L., et al. Bradykinin- and thrombin-induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation. J. Cell Physiol. 173 (1997) 387-396
3. Bazzoni G., and Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84 (2004) 869-901
4. Bensadoun E.S., et al. Proteoglycan deposition in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154 (1996) 1819-1828
5. Broussard J.A., et al. Asymmetric focal adhesion disassembly in motile cells. Curr. Opin. Cell Biol. 20 (2008) 85-90
6. Budde K., et al. FTY720 (fingolimod) in renal transplantation. Clin. Transplant. 17 20 Suppl (2006) 17-24
7. Cantor J.O., and Turino G.M. Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema?. Chest 125 (2004) 288-292
8. Carmeliet P., et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (1999) 147-157
9. Corada M., et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9815-9820
10. Dudek S.M., and Garcia J.G. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91 (2001) 1487-1500
11. Dudek S.M., et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J. Biol. Chem. 279 (2004) 24692-24700
12. Dudek S.M., et al. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal 19 (2007) 1754-1764
13. Ebnet K., et al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J. Biol. Chem. 275 (2000) 27979-27988
14. Finigan J.H., et al. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J. Biol. Chem. 280 (2005) 17286-17293
15. Furuse M., et al. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell Biol. 127 (1994) 1617-1626
16. Furuse M., et al. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J. Cell Biol. 147 (1999) 891-903
17. Garcia J.G., et al. Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60(src). Am. J. Physiol. 276 (1999) L989-L998
18. Garcia J.G., et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108 (2001) 689-701
19. Gimbrone Jr. M.A., et al. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 222 (1969) 33-36
20. Gosens R., et al. Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype. Eur. J. Pharmacol. 483 (2004) 71-78
21. Guo Y., et al. Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol. Cell Proteomics. 6 (2007) 689-696
22. Hait N.C. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta. 1758 (2006) 2016-2026
23. Hippenstiel S., et al. VEGF induces hyperpermeability by a direct action on endothelial cells. Am. J. Physiol. 274 (1998) L678-L684
24. Hla T., and Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265 (1990) 9308-9313
25. Hla T., et al. Lysophospholipids-receptor revelations. Science 294 (2001) 1875-1878
26. Jacobson J.R., and Garcia J.G. Novel therapies for microvascular permeability in sepsis. Curr. Drug Targets 8 (2007) 509-514
27. Kappos L., et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. 355 (2006) 1124-1140
28. Kapur S., et al. Recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 345 (2001) 219-220 (author reply 220-1)
29. Komarova Y.A., et al. Dual regulation of endothelial junctional permeability. Sci. STKE 2007 (2007) re8
30. Krump-Konvalinkova V., et al. Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 546-552
31. Lee J.F., et al. Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J. Biol. Chem. 281 (2006) 29190-29200
32. Lee M.J., et al. The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway. J. Biol. Chem. 271 (1996) 11272-11279
33. Lee M.J., et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279 (1998) 1552-1555
34. Lee M.J., et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99 (1999) 301-312
35. McVerry B.J., and Garcia J.G. Endothelial cell barrier regulation by sphingosine 1-phosphate. J. Cell Biochem. 92 (2004) 1075-1085
36. McVerry B.J., et al. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am. J. Respir. Crit. Care Med. 170 (2004) 987-993
37. Mehta D., and Malik A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86 (2006) 279-367
38. Mehta D., et al. Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier function. J. Physiol. 539 (2002) 779-789
39. Mehta D., et al. Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates rac activation and adherens junction assembly in endothelial cells. J. Biol. Chem. 280 (2005) 17320-17328
40. Michel C.C., and Curry F.E. Microvascular permeability. Physiol. Rev. 79 (1999) 703-761
41. Milici A.J., et al. Transcytosis of albumin in capillary endothelium. J. Cell Biol. 105 (1987) 2603-2612
42. Nitta T., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161 (2003) 653-660
43. Peng X., et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169 (2004) 1245-1251
44. Peters S.L., and Alewijnse A.E. Sphingosine-1-phosphate signaling in the cardiovascular system. Curr. Opin. Pharmacol. 7 (2007) 186-192
45. Predescu S.A., et al. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) L823-L842
46. Puybasset L., et al. A computed tomography scan assessment of regional lung volume in acute lung injury. The CT Scan ARDS Study Group. Am. J. Respir. Crit. Care Med. 158 (1998) 1644-1655
47. Quadri S.K., et al. Endothelial barrier strengthening by activation of focal adhesion kinase. J. Biol. Chem. 278 (2003) 13342-13349
48. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5 (2005) 560-570
49. Rotundo R.F., et al. TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (2002) L316-L329
50. Roy A.J., and Djerassi I. Effects of platelet transfusions: plug formation and maintenance of vascular integrity. Proc. Soc. Exp. Biol. Med. 139 (1972) 137-142
51. Schaphorst K.L., et al. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am. J. Physiol. Lung Cell Mol. Physiol. 285 (2003) L258-L267
52. Shikata Y., et al. Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. FASEB J. 17 (2003) 2240-2249
53. Shikata Y., et al. S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin. J. Appl. Physiol. 94 (2003) 1193-1203
54. Singleton P.A., et al. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 19 (2005) 1646-1656
55. Singleton P.A., et al. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J. Biol. Chem. 281 (2006) 34381-34393
56. Singleton P.A., et al. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am. J. Respir. Cell Mol. Biol. 37 (2007) 222-231
57. Tani M. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal 19 (2007) 229-237
58. Teran Arce F., et al. Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin. Biophys. J. 95 2 (2008) 886-894
59. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4 (2004) 528-539
60. Tzima E. Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response. Circ. Res. 98 (2006) 176-185
61. van Nieuw Amerongen G.P., et al. GIT1 mediates thrombin signaling in endothelial cells: role in turnover of RhoA-type focal adhesions. Circ. Res. 94 (2004) 1041-1049
62. Venkataraman K., et al. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem. J. 397 (2006) 461-471
63. Venkiteswaran K. Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin. Am. J. Physiol. Cell Physiol. 283 (2002) C811-C821
64. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 223-232
65. Vouret-Craviari V., et al. Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. J. Cell Sci. 115 (2002) 2475-2484
66. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342 (2000) 1334-1349
67. Waschke J., et al. Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier. Histochem. Cell Biol. 125 (2006) 397-406
68. Wojciak-Stothard B., et al. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 290 (2006) L1173-L1182
69. Xu M., et al. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Am. J. Physiol. Cell Physiol. 293 (2007) C1309-C1318
70. Yang L., et al. Metabolism and functional effects of sphingolipids in blood cells. Br. J. Haematol. 107 (1999) 282-293
71. Yatomi Y., et al. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86 (1995) 193-202